Compliance rates and outcomes associated with a restrictive transfusion policy in gynecologic oncology patients. (opens new window)

Boone JD, Kim KH, Marques M, Straughn JM.

Avots‎: Gynecol Oncol 2014;132(1):227-30.

Raksts indeksēts‎: PubMed 24512847

DOI‎: 10.1016/j.ygyno.2013.10.019

https://www.ncbi.nlm.nih.gov/pubmed/24512847 (opens new window)

Liberal or restrictive transfusion in high-risk patients after hip surgery. (opens new window)

Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, Nemo G, Dragert K, Beaupre L, Hildebrand K, Macaulay W, Lewis C, Cook DR, Dobbin G, Zakriya KJ, Apple FS, Horney RA, Magaziner J; FOCUS Investigators.

Avots‎: N Engl J Med 2011;365(26):2453-62.

Raksts indeksēts‎: PubMed 22168590

DOI‎: 10.1056/NEJMoa1012452

https://www.ncbi.nlm.nih.gov/pubmed/22168590 (opens new window)

Long-lasting extreme anemia during the therapy of acute lymphoblastic leukemia in a Jehovah's Witness patient. (opens new window)

Chojnowski K, Janus A, Bliźniewska K, Robak M, Treliński J.

Avots‎: Transfusion 2016;56(10):2438-42.

Raksts indeksēts‎: PubMed 27385671

DOI‎: 10.1111/trf.13703

https://www.ncbi.nlm.nih.gov/pubmed/27385671 (opens new window)

Autologous stem-cell transplantation without hematopoietic support for the treatment of hematologic malignancies in Jehovah's Witnesses. (opens new window)

Ford PA, Grant SJ, Mick R, Keck G.

Avots‎: J Clin Oncol 2015;33(15):1674-9.

Raksts indeksēts‎: PubMed 25870085

DOI‎: 10.1200/JCO.2014.57.9912

https://www.ncbi.nlm.nih.gov/pubmed/25870085 (opens new window)

Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions. (opens new window)

Friedmann AM, Sengul H, Lehmann H, Schwartz C, Goodman S.

Avots‎: Transfus Med Rev 2002;16(1):34-45.

Raksts indeksēts‎: PubMed 11788928

https://www.ncbi.nlm.nih.gov/pubmed/11788928 (opens new window)

A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. (opens new window)

Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E; Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group.

Avots‎: N Engl J Med 1999;340(6):409-17.

Raksts indeksēts‎: PubMed 9971864

DOI‎: 10.1056/NEJM199902113400601

https://www.ncbi.nlm.nih.gov/pubmed/9971864 (opens new window)

Red blood cell transfusion in non-bleeding critically ill patients with moderate anemia: is there a benefit? (opens new window)

Leal-Noval SR, Muñoz-Gómez M, Jiménez-Sánchez M, Cayuela A, Leal-Romero M, Puppo-Moreno A, Enamorado J, Arellano-Orden V.

Avots‎: Intensive Care Med 2013;39(3):445-53.

Raksts indeksēts‎: PubMed 23184038

DOI‎: 10.1007/s00134-012-2757-z

https://www.ncbi.nlm.nih.gov/pubmed/23184038 (opens new window)

How low should we go: A systematic review and meta-analysis of the impact of restrictive red blood cell transfusion strategies in oncology. (opens new window)

Prescott LS, Taylor JS, Lopez-Olivo MA, Munsell MF, VonVille HM, Lairson DR, Bodurka DC.

Avots‎: Cancer Treat Rev 2016;46:1-8.

Raksts indeksēts‎: PubMed 27046422

DOI‎: 10.1016/j.ctrv.2016.03.010

https://www.ncbi.nlm.nih.gov/pubmed/27046422 (opens new window)

Trends in red blood cell transfusion and 30-day mortality among hospitalized patients. (opens new window)

Roubinian NH, Escobar GJ, Liu V, Swain BE, Gardner MN, Kipnis P, Triulzi DJ, Gottschall JL, Wu Y, Carson JL, Kleinman SH, Murphy EL; NHLBI Recipient Epidemiology and Donor Evaluation Study (REDS-III).

Avots‎: Transfusion 2014;54(10 Pt 2):2678-86.

Raksts indeksēts‎: PubMed 25135770

DOI‎: 10.1111/trf.12825

https://www.ncbi.nlm.nih.gov/pubmed/25135770 (opens new window)

Liberal versus restrictive red blood cell transfusion thresholds in hematopoietic cell transplantation: a randomized, open label, phase III, noninferiority trial. (opens new window)

Tay J, Allan DS, Chatelain E, Coyle D, Elemary M, Fulford A, Petrcich W, Ramsay T, Walker I, Xenocostas A, Tinmouth A, Fergusson D

Avots‎: J Clin Oncol 2020;38(13):1463-73.

Raksts indeksēts‎: PubMed 32083994

DOI‎: 10.1200/JCO.19.01836

https://www.ncbi.nlm.nih.gov/pubmed/32083994 (opens new window)

Transfusion indications for patients with cancer. (opens new window)

Watkins T, Surowiecka MK, McCullough J.

Avots‎: Cancer Control 2015;22(1):38-46.

Raksts indeksēts‎: PubMed 25504277

https://www.ncbi.nlm.nih.gov/pubmed/25504277 (opens new window)

Restrictive blood transfusion protocol in malignant upper gastrointestinal and pancreatic resections patients reduces blood transfusions with no increase in patient morbidity. (opens new window)

Wehry J, Agle S, Philips P, Cannon R, Scoggins CR, Puffer L, McMasters KM, Martin RC.

Avots‎: Am J Surg 2015;210(6):1197-204.

Raksts indeksēts‎: PubMed 26602534

DOI‎: 10.1016/j.amjsurg.2015.08.013

https://www.ncbi.nlm.nih.gov/pubmed/26602534 (opens new window)